Fig. 1From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong KongFlow chart of the patient selection process. CRR, complete radiologic response. DAA, direct-acting anti-viral therapy. HCC, hepatocellular carcinoma. SVR, sustained virological responseBack to article page